These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
| (State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |||||||
|
|
|
|||||||
| (Address of Principal Executive Office) | (Zip Code) | |||||||
|
(
|
||
| (Registrant's telephone number, including area code) | ||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
| Large accelerated filer |
☐
|
|
☒
|
||||||||||||||
| Non-accelerated filer |
☐
|
Smaller Reporting Company |
|
||||||||||||||
| Emerging Growth Company |
|
||||||||||||||||
| Page | ||||||||||||||
| March 31, 2025 | December 31, 2024 | ||||||||||
| (Thousands of dollars, except share and per share data) | (Unaudited) | ||||||||||
| ASSETS | |||||||||||
| Cash, cash equivalents and restricted cash | $ |
|
$ |
|
|||||||
| Accounts receivable, net |
|
|
|||||||||
| Inventories, net |
|
|
|||||||||
| Prepaid expenses |
|
|
|||||||||
| Other current assets |
|
|
|||||||||
| TOTAL CURRENT ASSETS |
|
|
|||||||||
| Property, plant and equipment, net |
|
|
|||||||||
| Operating lease, right-of-use assets |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Other intangible assets, net |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| TOTAL ASSETS | $ |
|
$ |
|
|||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||
| Trade accounts payable | $ |
|
$ |
|
|||||||
| Notes payable to banks |
|
|
|||||||||
| Operating lease liabilities, current |
|
|
|||||||||
| Current portion of long-term debt |
|
|
|||||||||
| Accrued compensation and other benefits |
|
|
|||||||||
| Accrued expenses and other liabilities |
|
|
|||||||||
| Dividends payable |
|
|
|||||||||
| Income taxes payable |
|
|
|||||||||
| TOTAL CURRENT LIABILITIES |
|
|
|||||||||
| Long-term debt, less current portion |
|
|
|||||||||
| Operating lease liabilities, noncurrent |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other noncurrent liabilities |
|
|
|||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
|
Common shares – $
|
|
|
|||||||||
|
Common shares issued to rabbi trust,
|
(
|
(
|
|||||||||
| Deferred compensation liability |
|
|
|||||||||
| Paid-in capital |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
|
Treasury shares, at cost,
|
(
|
(
|
|||||||||
| Accumulated other comprehensive loss |
(
|
(
|
|||||||||
| TOTAL PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS' EQUITY |
|
|
|||||||||
| Noncontrolling interest |
|
|
|||||||||
| TOTAL SHAREHOLDERS' EQUITY |
|
|
|||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ |
|
$ |
|
|||||||
| Three Months Ended March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| (Thousands, except per share data) | ||||||||||||||
| Net sales | $ |
|
$ |
|
||||||||||
| Cost of products sold |
|
|
||||||||||||
| GROSS PROFIT |
|
|
||||||||||||
| Costs and expenses | ||||||||||||||
| Selling |
|
|
||||||||||||
| General and administrative |
|
|
||||||||||||
| Research and engineering |
|
|
||||||||||||
| Other operating expense (income), net |
|
(
|
||||||||||||
|
|
|
|||||||||||||
| OPERATING INCOME |
|
|
||||||||||||
| Other income (expense) | ||||||||||||||
| Interest income |
|
|
||||||||||||
| Interest expense |
(
|
(
|
||||||||||||
| Other income, net |
|
|
||||||||||||
|
|
|
|||||||||||||
| INCOME BEFORE INCOME TAXES |
|
|
||||||||||||
| Income tax expense |
|
|
||||||||||||
| NET INCOME | $ |
|
$ |
|
||||||||||
| Net income attributable to noncontrolling interests |
(
|
(
|
||||||||||||
| NET INCOME ATTRIBUTABLE TO PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS | $ |
|
$ |
|
||||||||||
| AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING: | ||||||||||||||
| Basic |
|
|
||||||||||||
| Diluted |
|
|
||||||||||||
| EARNINGS PER SHARE OF COMMON STOCK ATTRIBUTABLE TO PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS: | ||||||||||||||
| Basic | $ |
|
$ |
|
||||||||||
| Diluted | $ |
|
$ |
|
||||||||||
| Three Months Ended March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| (Thousands of dollars) | ||||||||||||||
| Net income | $ |
|
$ |
|
||||||||||
| Other comprehensive income (loss), net of tax: | ||||||||||||||
| Foreign currency translation adjustment |
|
(
|
||||||||||||
| Pension adjustment, net of tax |
|
|
||||||||||||
| Other comprehensive income (loss), net of tax |
|
(
|
||||||||||||
| Comprehensive income attributable to noncontrolling interests |
(
|
(
|
||||||||||||
| COMPREHENSIVE INCOME ATTRIBUTABLE TO PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS | $ |
|
$ |
|
||||||||||
| Three Months Ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| (Thousands of dollars) | |||||||||||
| OPERATING ACTIVITIES | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash provided by operations: | |||||||||||
| Depreciation and amortization |
|
|
|||||||||
| Deferred income taxes |
(
|
(
|
|||||||||
| Share-based compensation expense |
|
|
|||||||||
| Gain on sale of property and equipment |
(
|
(
|
|||||||||
| Other, net |
(
|
|
|||||||||
| Changes in operating assets and liabilities |
(
|
(
|
|||||||||
| NET CASH PROVIDED BY OPERATING ACTIVITIES |
|
|
|||||||||
| INVESTING ACTIVITIES | |||||||||||
| Capital expenditures |
(
|
(
|
|||||||||
| Proceeds from the sale of property and equipment |
|
|
|||||||||
| Proceeds from sale of investments |
|
|
|||||||||
| Purchases of investments |
(
|
|
|||||||||
| NET CASH USED IN INVESTING ACTIVITIES |
(
|
(
|
|||||||||
| FINANCING ACTIVITIES | |||||||||||
| Payments of notes payable to banks |
(
|
(
|
|||||||||
| Proceeds from long-term debt |
|
|
|||||||||
| Payments of long-term debt |
(
|
(
|
|||||||||
| Dividends paid |
(
|
(
|
|||||||||
| Proceeds from issuance of common shares |
|
|
|||||||||
| Stock incentive plan payments |
(
|
|
|||||||||
| Purchase of common shares for treasury |
(
|
|
|||||||||
| Purchase of common shares for treasury from related parties |
(
|
(
|
|||||||||
| NET CASH USED IN FINANCING ACTIVITIES |
(
|
(
|
|||||||||
| Effects of exchange rate changes on cash, cash equivalents and restricted cash |
|
(
|
|||||||||
| Net decrease in cash, cash equivalents and restricted cash |
(
|
(
|
|||||||||
| Cash, cash equivalents and restricted cash at beginning of year |
|
|
|||||||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD | $ |
|
$ |
|
|||||||
|
Accumulated Other
Comprehensive Income (Loss) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In thousands, except share and per share data) | Common Shares | Common Shares Issued to Rabbi Trust | Deferred Compensation Liability | Paid in Capital | Retained Earnings | Treasury Shares | Cumulative Translation Adjustment | Unrecognized Pension Benefit Cost | Total Preformed Line Products Company Equity | Noncontrolling Interests | Total Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2024 | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustment |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pension adjustment, net of tax |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total comprehensive income |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Purchase of
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stock incentive plan activity
|
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Common shares issued to rabbi trust of
|
(
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cash dividends declared – $
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2025 | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common Shares | Common Shares Issued to Rabbi Trust | Deferred Compensation Liability | Paid in Capital | Retained Earnings | Treasury Shares | Cumulative Translation Adjustment | Unrecognized Pension Benefit Cost | Total Preformed Line Products Company Equity | Noncontrolling Interests | Total Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2023 | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustment |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pension adjustment, net of tax |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total comprehensive income |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stock incentive plan activity
|
|
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Common shares distributed from rabbi trust of
|
(
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cash dividends declared – $
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2024 | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||
| Product Type | PLP-USA | The Americas | EMEA | Asia-Pacific | Consolidated | ||||||||||||
| Energy |
|
|
|
|
|
||||||||||||
| Communications |
|
|
|
|
|
||||||||||||
| Special Industries |
|
|
|
|
|
||||||||||||
| Total |
|
|
|
|
|
||||||||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||
| Product Type | PLP-USA | The Americas | EMEA | Asia-Pacific | Consolidated | ||||||||||||
| Energy |
|
|
|
|
|
||||||||||||
| Communications |
|
|
|
|
|
||||||||||||
| Special Industries |
|
|
|
|
|
||||||||||||
| Total |
|
|
|
|
|
||||||||||||
| Three Months Ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Allowance for credit losses, beginning of period | $ |
|
$ |
|
|||||||
| (Reductions) additions charged to costs and expenses |
(
|
|
|||||||||
| Write-offs |
|
(
|
|||||||||
| Foreign exchange and other |
|
(
|
|||||||||
| Allowance for credit losses, end of period | $ |
|
$ |
|
|||||||
| March 31, 2025 | December 31, 2024 | ||||||||||
| Raw materials | $ |
|
$ |
|
|||||||
| Work-in-process |
|
|
|||||||||
| Finished products |
|
|
|||||||||
| Inventories, net of excess and obsolete inventory reserve |
|
|
|||||||||
| Excess of current cost over LIFO cost |
(
|
(
|
|||||||||
| Inventories at LIFO cost | $ |
|
$ |
|
|||||||
| March 31, 2025 | December 31, 2024 | ||||||||||
| Land and improvements | $ |
|
$ |
|
|||||||
| Buildings and improvements |
|
|
|||||||||
| Machinery, equipment and aircraft |
|
|
|||||||||
| Construction in progress |
|
|
|||||||||
| Property, plant and equipment, gross |
|
|
|||||||||
| Less accumulated depreciation |
(
|
(
|
|||||||||
| Property, plant and equipment, net | $ |
|
$ |
|
|||||||
| Three Months Ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Interest cost | $ |
|
$ |
|
|||||||
| Expected return on plan assets |
(
|
(
|
|||||||||
| Recognized net actuarial loss |
|
|
|||||||||
| Net periodic pension expense | $ |
|
$ |
|
|||||||
| Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||||||||||
|
Unrecognized
Benefit Cost |
Cumulative
Translation Adjustment |
Total
|
Unrecognized
Benefit Cost |
Cumulative
Translation Adjustment |
Total
|
||||||||||||||||||||||||||||||
| Balance at January 1 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
| Other comprehensive income before reclassifications: | |||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustment | — |
|
|
— |
(
|
(
|
|||||||||||||||||||||||||||||
| Amounts reclassified from AOCI: | |||||||||||||||||||||||||||||||||||
| Amortization of defined benefit pension actuarial loss (a) |
|
— |
|
|
— |
|
|||||||||||||||||||||||||||||
| Net current period other comprehensive income (loss) |
|
|
|
|
(
|
(
|
|||||||||||||||||||||||||||||
| Balance at March 31 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
| Three Months Ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Numerator | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Denominator | |||||||||||
| Determination of shares (in thousands) | |||||||||||
| Weighted-average common shares outstanding |
|
|
|||||||||
| Dilutive effect – share-based awards |
|
|
|||||||||
| Diluted weighted-average common shares outstanding |
|
|
|||||||||
| Earnings per common share | |||||||||||
| Basic | $ |
|
$ |
|
|||||||
| Diluted | $ |
|
$ |
|
|||||||
| March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||
|
Gross Carrying
Amount
|
Accumulated
Amortization |
Gross Carrying
Amount
|
Accumulated
Amortization |
||||||||||||||||||||
| Finite-lived intangible assets | |||||||||||||||||||||||
| Patents | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
| Land use rights |
|
(
|
|
(
|
|||||||||||||||||||
| Trademark |
|
(
|
|
(
|
|||||||||||||||||||
| Technology |
|
(
|
|
(
|
|||||||||||||||||||
| Customer relationships |
|
(
|
|
(
|
|||||||||||||||||||
| $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||
| Indefinite-lived intangible assets | |||||||||||||||||||||||
| Goodwill | $ |
|
$ |
|
|||||||||||||||||||
| PLP-USA | The Americas | EMEA | Asia-Pacific | Total | |||||||||||||||||||||||||
| Balance at January 1, 2025 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Currency translation |
|
|
|
|
|
||||||||||||||||||||||||
| Balance at March 31, 2025 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Description |
Balance as of
March 31, 2025 |
Quoted Prices in Active Markets for
Identical Assets or Liabilities
(Level 1)
|
Significant Other Observable Inputs
(Level 2)
|
Significant Unobservable Inputs
(Level 3)
|
||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||
| Foreign currency forward contracts | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Fixed income investments
|
|
|
|
|
||||||||||||||||||||||
| Total assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Liabilities: | ||||||||||||||||||||||||||
| Foreign currency forward contracts | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Supplemental profit sharing plan |
|
|
|
|
||||||||||||||||||||||
| Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Description | Balance as of December 31, 2024 |
Quoted Prices in Active Markets for
Identical Assets or Liabilities
(Level 1)
|
Significant Other Observable Inputs
(Level 2)
|
Significant Unobservable Inputs
(Level 3)
|
||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||
| Foreign currency forward contracts | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Fixed income investments
|
|
|
|
|
||||||||||||||||||||||
| Total assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Liabilities: | ||||||||||||||||||||||||||
| Foreign currency forward contracts | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Supplemental profit sharing plan |
|
|
|
|
||||||||||||||||||||||
| Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||
|
Fair Value
|
Carrying Value | Fair Value | Carrying Value | ||||||||||||||||||||
| Long-term debt and related current maturities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||||||||||||||
| PLP-USA | The Americas | EMEA | Asia-Pacific | Total | |||||||||||||||||||||||||
|
Gross sales
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
|
Intersegment sales
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
|
Net sales
|
|
|
|
|
|
||||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||
|
Cost of products sold
|
|
|
|
|
|
||||||||||||||||||||||||
|
Gross profit
|
|
|
|
|
|
||||||||||||||||||||||||
| Costs and expenses |
|
|
|
|
|
||||||||||||||||||||||||
|
Operating income
|
|
|
|
|
|
||||||||||||||||||||||||
|
Interest income
|
|
|
|
|
|
||||||||||||||||||||||||
|
Interest expense
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
| Other (expense) income, net |
(
|
|
|
|
|
||||||||||||||||||||||||
| Income before income taxes |
|
|
|
|
|
||||||||||||||||||||||||
|
Income tax expense
|
|
|
|
|
|
||||||||||||||||||||||||
|
Total noncontrolling interest
|
|
|
(
|
|
(
|
||||||||||||||||||||||||
|
Total net income attributable to Preformed Line Products Company shareholders
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||||||||||||||
| PLP-USA | The Americas | EMEA | Asia-Pacific | Total | |||||||||||||||||||||||||
| Gross sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Intersegment sales |
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
| Net sales |
|
|
|
|
|
||||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||
| Cost of products sold |
|
|
|
|
|
||||||||||||||||||||||||
| Gross profit |
|
|
|
|
|
||||||||||||||||||||||||
| Costs and expenses |
|
|
|
|
|
||||||||||||||||||||||||
| Operating income |
|
|
|
|
|
||||||||||||||||||||||||
| Interest income |
|
|
|
|
|
||||||||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
| Other (expense) income, net |
(
|
|
|
|
|
||||||||||||||||||||||||
| Income before income taxes |
|
|
|
|
|
||||||||||||||||||||||||
| Income tax expense |
|
|
|
|
|
||||||||||||||||||||||||
| Total noncontrolling interest |
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Total net income attributable to Preformed Line Products Company shareholders | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| Expenditure for long-lived assets | |||||||||||||||||
| PLP-USA | $ |
|
$ |
|
|||||||||||||
| The Americas |
|
|
|||||||||||||||
| EMEA |
|
|
|||||||||||||||
| Asia-Pacific |
|
|
|||||||||||||||
| Total expenditure for long-lived assets | $ |
|
$ |
|
|||||||||||||
| Depreciation and amortization | |||||||||||||||||
| PLP-USA | $ |
|
$ |
|
|||||||||||||
| The Americas |
|
|
|||||||||||||||
| EMEA |
|
|
|||||||||||||||
| Asia-Pacific |
|
|
|||||||||||||||
| Total depreciation and amortization | $ |
|
$ |
|
|||||||||||||
| March 31, 2025 | December 31, 2024 | ||||||||||
| Identifiable assets | |||||||||||
| PLP-USA | $ |
|
$ |
|
|||||||
| The Americas |
|
|
|||||||||
| EMEA |
|
|
|||||||||
| Asia-Pacific |
|
|
|||||||||
| Total identifiable assets | $ |
|
$ |
|
|||||||
|
Long-lived assets
|
|||||||||||
| PLP-USA | $ |
|
$ |
|
|||||||
| The Americas |
|
|
|||||||||
| EMEA |
|
|
|||||||||
| Asia-Pacific |
|
|
|||||||||
|
Total long-lived assets
|
$ |
|
$ |
|
|||||||
| Foreign Currency Translation Impact | |||||||||||||||||||||||
| Net Sales | Net Income | ||||||||||||||||||||||
| (Thousands of dollars) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||
| The Americas | $ | (3,204) | $ | 805 | $ | (206) | $ | 33 | |||||||||||||||
| EMEA | (440) | 788 | 30 | 39 | |||||||||||||||||||
| Asia-Pacific | (751) | (844) | (47) | (73) | |||||||||||||||||||
| Total | $ | (4,395) | $ | 749 | $ | (223) | $ | (1) | |||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||||||||||||||
| (Thousands of dollars) | 2025 | 2024 | |||||||||||||||||||||||||||
| Net sales | $ | 148,541 | 100.0 | % | $ | 140,904 | 100.0 | % | $ | 7,637 | |||||||||||||||||||
| Cost of products sold | 99,870 | 67.2 | 96,773 | 68.7 | 3,097 | ||||||||||||||||||||||||
| GROSS PROFIT | 48,671 | 32.8 | 44,131 | 31.3 | 4,540 | ||||||||||||||||||||||||
| Costs and expenses | 35,541 | 23.9 | 32,572 | 23.1 | 2,969 | ||||||||||||||||||||||||
| OPERATING INCOME | 13,130 | 8.8 | 11,559 | 8.2 | 1,571 | ||||||||||||||||||||||||
| Other income, net | 541 | 0.4 | 299 | 0.2 | 242 | ||||||||||||||||||||||||
| INCOME BEFORE INCOME TAXES | 13,671 | 9.2 | 11,858 | 8.4 | 1,813 | ||||||||||||||||||||||||
| Income taxes | 2,118 | 1.4 | 2,255 | 1.6 | (137) | ||||||||||||||||||||||||
| NET INCOME | 11,553 | 7.8 | 9,603 | 6.8 | 1,950 | ||||||||||||||||||||||||
| Net income attributable to noncontrolling interests | (36) | 0.0 | (7) | 0.0 | (29) | ||||||||||||||||||||||||
| NET INCOME ATTRIBUTABLE TO PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS | $ | 11,517 | 7.8 | % | $ | 9,596 | 6.8 | % | $ | 1,921 | |||||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||
| (Thousands of dollars) | 2025 | 2024 | Change |
Change
Due to
Currency
Translation
|
Change
Excluding
Currency
Translation
|
%
Change
|
|||||||||||||||||||||||||||||
| Net sales | |||||||||||||||||||||||||||||||||||
| PLP-USA | $ | 74,006 | $ | 70,737 | $ | 3,269 | $ | — | $ | 3,269 | 5 | % | |||||||||||||||||||||||
| The Americas | 22,279 | 18,358 | 3,921 | (3,204) | 7,125 | 39 | % | ||||||||||||||||||||||||||||
| EMEA | 29,993 | 28,654 | 1,339 | (440) | 1,779 | 6 | % | ||||||||||||||||||||||||||||
| Asia-Pacific | 22,263 | 23,155 | (892) | (751) | (141) | (1) | % | ||||||||||||||||||||||||||||
| Consolidated | $ | 148,541 | $ | 140,904 | $ | 7,637 | $ | (4,395) | $ | 12,032 | 9 | % | |||||||||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||
| (Thousands of dollars) | 2025 | 2024 | Change |
Change
Due to
Currency
Translation
|
Change
Excluding
Currency
Translation
|
%
Change
|
|||||||||||||||||||||||||||||
| Gross profit | |||||||||||||||||||||||||||||||||||
| PLP-USA | $ | 26,838 | $ | 24,696 | $ | 2,142 | $ | — | $ | 2,142 | 9 | % | |||||||||||||||||||||||
| The Americas | 7,087 | 4,965 | 2,122 | (1,026) | 3,148 | 63 | % | ||||||||||||||||||||||||||||
| EMEA | 8,877 | 8,318 | 559 | (81) | 640 | 8 | % | ||||||||||||||||||||||||||||
| Asia-Pacific | 5,869 | 6,152 | (283) | (208) | (75) | (1) | % | ||||||||||||||||||||||||||||
| Consolidated | $ | 48,671 | $ | 44,131 | $ | 4,540 | $ | (1,315) | $ | 5,855 | 13 | % | |||||||||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||||||||
| (Thousands of dollars) | 2025 | 2024 | Change |
Change
Due to
Currency
Translation
|
Change Due to Intercompany Transactions |
Change Excluding
Currency
and Intercompany Transactions
|
%
Change
|
||||||||||||||||||||||||||||||||||
| Costs and expenses | |||||||||||||||||||||||||||||||||||||||||
| PLP-USA | $ | 17,154 | $ | 18,164 | $ | (1,010) | $ | — | $ | (1,799) | $ | 789 | 4 | % | |||||||||||||||||||||||||||
| The Americas | 5,488 | 4,721 | 767 | (617) | 954 | 430 | 9 | % | |||||||||||||||||||||||||||||||||
| EMEA | 7,350 | 6,129 | 1,221 | (115) | 473 | 863 | 14 | % | |||||||||||||||||||||||||||||||||
| Asia-Pacific | 5,549 | 3,558 | 1,991 | (131) | 372 | 1,750 | 49 | % | |||||||||||||||||||||||||||||||||
| Consolidated | $ | 35,541 | $ | 32,572 | $ | 2,969 | $ | (863) | $ | — | $ | 3,832 | 12 | % | |||||||||||||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||
| (Thousands of dollars) | 2025 | 2024 | Change |
Change
Due to
Currency
Translation
|
Change
Excluding
Currency
Translation
|
%
Change
|
|||||||||||||||||||||||||||||
| Net income (loss) | |||||||||||||||||||||||||||||||||||
| PLP-USA | $ | 8,437 | $ | 5,317 | $ | 3,120 | $ | — | $ | 3,120 | 59 | % | |||||||||||||||||||||||
| The Americas | 1,396 | 897 | 499 | (206) | 705 | 79 | % | ||||||||||||||||||||||||||||
| EMEA | 1,188 | 1,579 | (391) | 30 | (421) | (27) | % | ||||||||||||||||||||||||||||
| Asia-Pacific | 496 | 1,803 | (1,307) | (47) | (1,260) | (70) | % | ||||||||||||||||||||||||||||
| Consolidated | $ | 11,517 | $ | 9,596 | $ | 1,921 | $ | (223) | $ | 2,144 | 22 | % | |||||||||||||||||||||||
| Period |
Total
Number of Shares Purchased |
Average
Price Paid per Share ($) |
Total Number of
Shares Purchased as Part of Publicly Announced Plans or Programs |
Maximum Number
of Shares that may yet be Purchased under the Plans or Programs |
||||||||||||||||||||||
| January | 6,722 | $ | 131.09 | 6,722 | 172,775 | |||||||||||||||||||||
| February | — | $ | — | — | 172,775 | |||||||||||||||||||||
| March | 860 | $ | 152.34 | 860 | 171,915 | |||||||||||||||||||||
| Total | 7,582 | |||||||||||||||||||||||||
|
Exhibit
Number |
Exhibit | |||||||
| 10.1 | ||||||||
| 10.2 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101.INS | Inline XBRL Instance Document. | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |||||||
| 104 | Cover Page Interactive Data File (embedded within the inline XBRL document) | |||||||
| Preformed Line Products Company | ||||||||
| May 2, 2025 | /s/ Robert G. Ruhlman | |||||||
| Robert G. Ruhlman | ||||||||
| Executive Chairman | ||||||||
| (principal executive officer) | ||||||||
| May 2, 2025 | /s/ Andrew S. Klaus | |||||||
| Andrew S. Klaus | ||||||||
| Chief Financial Officer | ||||||||
| (principal financial and accounting officer) | ||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|